Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.

SAR exploration of the 2,4-diamino-6,7-dimethoxyquinazoline template led to the discovery of 8 (UNC0224) as a potent and selective G9a inhibitor. A high resolution X-ray crystal structure of the G9a-8 complex, the first cocrystal structure of G9a with a small molecule inhibitor, was obtained. The cocrystal structure validated our binding hypothesis and will enable structure-based design of novel inhibitors. 8 is a useful tool for investigating the biology of G9a and its roles in chromatin remodeling.

[1]  C. Ponting,et al.  Regulation of chromatin structure by site-specific histone H3 methyltransferases , 2000, Nature.

[2]  Kelly M. McGarvey,et al.  Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. , 2006, Cancer research.

[3]  E. Lander,et al.  The Mammalian Epigenome , 2007, Cell.

[4]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[5]  Axel Imhof,et al.  Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9 , 2005, Nature chemical biology.

[6]  Abdellah Allali-Hassani,et al.  L3MBTL1 recognition of mono- and dimethylated histones , 2007, Nature Structural &Molecular Biology.

[7]  Wolfgang Fischle,et al.  Role of histone modifications in defining chromatin structure and function , 2008, Biological chemistry.

[8]  Karl Mechtler,et al.  Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. , 2007, Molecular cell.

[9]  Frank Lyko,et al.  DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. , 2005, Journal of the National Cancer Institute.

[10]  Cyrus Martin,et al.  The diverse functions of histone lysine methylation , 2005, Nature Reviews Molecular Cell Biology.

[11]  A. Lund,et al.  Chromatin‐modifying proteins in cancer , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[12]  J. Snyder,et al.  Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294 , 2009, Nature Structural &Molecular Biology.

[13]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[14]  M. Esteller.  Epigenetics in cancer. , 2008, The New England journal of medicine.

[15]  P. Cole,et al.  Chemical probes for histone-modifying enzymes. , 2008, Nature chemical biology.

[16]  Anton Simeonov,et al.  A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors. , 2010, Molecular bioSystems.

[17]  Stacie L. Bulfer,et al.  A coupled fluorescent assay for histone methyltransferases. , 2005, Analytical biochemistry.

[18]  J. Issa,et al.  Downregulation of Histone H3 Lysine 9 Methyltransferase G9a Induces Centrosome Disruption and Chromosome Instability in Cancer Cells , 2008, PloS one.

[19]  W. Sippl,et al.  Cancer treatment of the future: inhibitors of histone methyltransferases. , 2009, The international journal of biochemistry & cell biology.

[20]  C. Allis,et al.  Translating the Histone Code , 2001, Science.